AMGN vs KD · P/E 24, rev $10.05B vs P/E 14, rev $15.09B
Amgen Inc (AMGN) versus Kyndryl Holdings Inc (KD) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Kyndryl Holdings Inc (KD) is a information technology services company listed on NYSE.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported KD revenue for 2026-03-31 was $15.09B. Net income was $198.0M. Revenue was up 0.2% from 2025-03-31 to 2026-03-31. KD currently screens at market cap $2.69B and trailing P/E 14.4.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. KD currently screens at market cap $2.69B and trailing P/E 14.4.
Not investment advice. Open the AMGN and KD stock pages for the full models.
Not investment advice.